Literature DB >> 24344017

Stress protein Hsp27 expression predicts the outcome in operated small cell lung carcinoma and large cell neuroendocrine carcinoma patients.

D M Marinova1, Y G Slavova, N Trifonova, D Kostadinov, V Maksimov, D Petrov.   

Abstract

PURPOSE: Heat shock protein (Hsp)27 is overexpressed in a range of human cancers and is implicated in tumor cell proliferation, differentiation, invasion, metastasis, and survival. The aim of the present study was to determine the prognostic significance of Hsp27 expression in small cell lung carcinoma (SCLC) and large cell neuroendocrine carcinoma (LCNEC).
METHODS: Surgically resected SCLCs (N=51) and LCNECs (N=15) were studied. The Hsp27 expression was detected immunohistochemically.
RESULTS: Hsp27 positive immunoreaction in the cytoplasm was observed in 45 (88%) SCLCs and 14 (93%) LCNECs. A combination of cytoplasmic with nuclear Hsp27 expression was observed in 28 (62%) SCLCs and 14 (100%) LCNECs. There was a correlation between Hsp27 cytoplasmic overexpression and Hsp27 nuclear expression with patient survival confirmed by Cox multivariate analysis.
CONCLUSION: We conclude that the higher Hsp27 cytoplasmic expression and nuclear expression may represent favorable prognostic factors in SCLC and LCNEC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24344017

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  2 in total

1.  Reliable Entity Subtyping in Non-small Cell Lung Cancer by Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry on Formalin-fixed Paraffin-embedded Tissue Specimens.

Authors:  Mark Kriegsmann; Rita Casadonte; Jörg Kriegsmann; Hendrik Dienemann; Peter Schirmacher; Jan Hendrik Kobarg; Kristina Schwamborn; Albrecht Stenzinger; Arne Warth; Wilko Weichert
Journal:  Mol Cell Proteomics       Date:  2016-07-29       Impact factor: 5.911

2.  Heat shock protein 27 promotes cell proliferation through activator protein-1 in lung cancer.

Authors:  Sai Zhang; Yangmin Hu; Yuwen Huang; Huimin Xu; Gongxiong Wu; Haibin Dai
Journal:  Oncol Lett       Date:  2015-03-26       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.